Physician profile
Robert E Elvington
NPI 1679587232
$2,418.41
in general payments reported to CMS, 2019-2025
4 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.68 · 2021: $443 · 2022: $206 · 2023: $22.42 · 2024: $1,479 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,370 · Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,370.41 |
| Food and Beverage | $365.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,298.30 | 2020-2025 | Mako, Gamma, Triathlon |
| Peerless Surgical INC. | $49.63 | 2025 | |
| Depuy Synthes Sales INC. | $48.06 | 2025 | Tfn-Advance |
| Smith+Nephew, INC. | $22.42 | 2023 | Stravix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Elvington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.